Dr James Flanagan and Dr Hannah Brewer from Imperial College London talk through the CLOCS-1 study
500 women without ovarian cancer
and
500 women with ovarian cancer
can help
identify if patients were more likely to purchase certain products to manage the signs and symptoms of ovarian cancer before seeing a health professional,
testing for the effectiveness of using loyalty cards for early cancer diagnosis,
and
help us understand public preferences for how to communicate our findings effectively back to the patients and the public.
Funding
The Cancer Loyalty Card Study (CLOCS) is being organised by the CLOCS research team and sponsored by Imperial College London. This research is being funded by a Cancer Research UK Early Detection Project Grant (C38463/A26726).
Ethical Approvals
The study was first reviewed by patient representatives and edited accordingly. The pilot study was reviewed and received a favourable opinion from the University College London Ethics Committee and Consumer Data Research Centre (CDRC) at UCL, London. The project grant was reviewed by the Cancer Research UK Early Detection committee. The first CLOCS study, namely the case-control study, has also been reviewed by the North West – GM South Research Ethics Committee and received favourable opinion on 11/09/2019 (REC reference: 19/NW/0427).